News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Pharm Country
Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
August 7, 2023
·
7 min read
STD Diagnostics Market Size, Trends, Company Analysis and Forecast 2023-2032
August 4, 2023
·
11 min read
Medexus to Participate in Fireside Chat at SHARE Series Event
August 4, 2023
·
2 min read
Therma Bright Provides Update on Venowave’s Permanent CPT/HCPCS Codes and United States Distribution Partners
August 4, 2023
·
4 min read
PlasCred Circular Innovations Inc. Completes Business Combination Transaction
August 4, 2023
·
8 min read
Business
Adaptimmune to Report Q2 2023 Financial and Business Updates on Wednesday, August 9, 2023
August 3, 2023
·
2 min read
Policy
Solarvest Receipt of Notice of Requisition of a Meeting of Shareholders
August 3, 2023
·
1 min read
Business
Kiora Pharmaceuticals, Inc. and Choroideremia Research Foundation Partner to Advance Novel Choroideremia Treatment
August 3, 2023
·
5 min read
Lone Star Bio
Maxwell Biosciences Announces Publication of Mechanism of Action Study: Claromer Compounds Target Pathogens by Disrupting Their Membranes
August 2, 2023
·
4 min read
Medexus Schedules First Fiscal Quarter 2024 Conference Call
August 2, 2023
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us